Protalix BioTherapeutics, Inc. — Investor Relations & Filings
Filings indexed
950
across all filing types
Latest filing
2026-05-21
Regulatory Filings
Country
US
United States of America
Listing
US
PLX
Protalix BioTherapeutics, Inc. is a biopharmaceutical company that develops, produces, and commercializes recombinant therapeutic proteins. The company's unique selling point is its proprietary ProCellEx® platform, a plant cell-based protein expression system used to manufacture complex proteins. This technology supports the development of treatments for rare and orphan diseases. Protalix has successfully brought enzyme replacement therapies to market and maintains a pipeline of product candidates targeting conditions with high unmet medical needs. The company's capabilities cover the entire process from protein candidate selection and genetic engineering of plant cells through preclinical and clinical development to commercial-scale production and marketing.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-21 | English | |
| 10-Q - Protalix BioTherapeutics, Inc. (0001006281) (Filer) | 2026-05-13 | English | |
| 8-K - Protalix BioTherapeutics, Inc. (0001006281) (Filer) | 2026-05-13 | English | |
| SCHEDULE 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject) | 2026-03-30 | English | |
| 8-K Filing | 2026-02-11 | English | |
| 8-K Filing | 2026-01-30 | English |
Browse filings by year
31 years- 2026 7 filings
- 2025 39 filings
- 2024 22 filings
- 2023 41 filings
- 2022 47 filings
- 2021 39 filings
- 2020 55 filings
- 2019 49 filings
- 2018 46 filings
- 2017 43 filings
- 2016 33 filings
- 2015 48 filings
- 2014 35 filings
- 2013 27 filings
- 2012 46 filings
- 2011 37 filings
- 2010 50 filings
- 2009 70 filings
- 2008 43 filings
- 2007 91 filings
- 2006 10 filings
- 2005 12 filings
- 2004 7 filings
- 2003 4 filings
- 2002 5 filings
- 2001 6 filings
- 2000 5 filings
- 1999 11 filings
- 1998 10 filings
- 1997 10 filings
- 1996 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 46729571 | 8-K | 2026-05-21 | English | ||
| 45556339 | 10-Q - Protalix BioTherapeutics, Inc. (0001006281) (Filer) | 2026-05-13 | English | ||
| 45553317 | 8-K - Protalix BioTherapeutics, Inc. (0001006281) (Filer) | 2026-05-13 | English | ||
| 33092888 | SCHEDULE 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject) | 2026-03-30 | English | ||
| 26201293 | 8-K Filing | 2026-02-11 | English | ||
| 26201277 | 8-K Filing | 2026-01-30 | English | ||
| 26201262 | 8-K Filing | 2026-01-05 | English | ||
|
2025
8 filings
| |||||
| 26201245 | 4 Filing | 2025-12-23 | English | ||
| 10684752 | Director's Dealing 2025 | 2025-11-19 | English | ||
| 10684767 | 10-Q | 2025-11-13 | English | ||
| 10684774 | 8-K | 2025-11-13 | English | ||
| 10684782 | 8-K | 2025-11-03 | English | ||
| 10684793 | 8-K | 2025-10-17 | English | ||
| 10684799 | Director's Dealing 2025 | 2025-09-04 | English | ||
| 10684796 | Director's Dealing 2025 | 2025-09-04 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
Protalix BioTherapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33807/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33807 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33807 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33807 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33807}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Protalix BioTherapeutics, Inc. (id: 33807)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.